Molecular Genetics in Carcinoma of the Bladder
Data up to Jan 2025
Total Citations Per Year
Abstract
References (114)
Molecular Cloning: A Laboratory Manual
2001 • 133,517 citations
A genetic model for colorectal tumorigenesis
1990 • 11,800 citations
p53 Mutations in Human Cancers
1991 • 8,133 citations
A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4
1993 • 3,680 citations
Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction
1989 • 3,557 citations
Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.
1994 • 3,536 citations
A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma
1986 • 2,968 citations
A Cell Cycle Regulator Potentially Involved in Genesis of Many Tumor Types
1994 • 2,821 citations
Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis
1993 • 2,711 citations
Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer
1993 • 2,282 citations
Chromosome 17 Deletions and p53 Gene Mutations in Colorectal Carcinomas
1989 • 2,081 citations
A hypervariable microsatellite revealed by in vitro amplification of a dinucleotide repeat within the cardiac muscle actin gene.
1989 • 2,011 citations
5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers
1995 • 2,000 citations
Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus
1990 • 1,882 citations
Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers
1994 • 1,806 citations
The Molecular Genetics of Cancer
1987 • 1,729 citations
Informativeness of human (dC-dA)n · (dG-dT)n polymorphisms
1990 • 1,371 citations
Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53
1992 • 1,358 citations
Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers.
1995 • 1,353 citations
Functional inactivation of genes by dominant negative mutations
1987 • 1,174 citations
Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles
1992 • 1,117 citations
Cold Spring Harbor Laboratory
1995 • 1,077 citations
Abnormalities in Structure and Expression of the Human Retinoblastoma Gene in SCLC
1988 • 905 citations
Identification of p53 Gene Mutations in Bladder Cancers and Urine Samples
1991 • 891 citations
Cancer statistics, 1990
1990 • 818 citations
p53: oncogene or anti-oncogene?
1990 • 812 citations
Transforming genes of human bladder and lung carcinoma cell lines are homologous to the ras genes of Harvey and Kirsten sarcoma viruses.
1982 • 775 citations
p53 functions as a cell cycle control protein in osteosarcomas.
1990 • 774 citations
Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing.
1995 • 713 citations
The retinoblastoma gene product regulates progression through the G1 phase of the cell cycle
1991 • 708 citations
Frequency of homozygous deletion at p16/CDKN2 in primary human tumours
1995 • 653 citations
Suppression of Tumorigenicity of Human Prostate Carcinoma Cells by Replacing a Mutated RB Gene
1990 • 606 citations
Two molecular pathways to transitional cell carcinoma of the bladder.
1994 • 599 citations
Chromosome Aberrations and Cancer
1991 • 598 citations
Nuclear Overexpression of p53 Protein in Transitional Cell Bladder Carcinoma: A Marker for Disease Progression
1993 • 544 citations
Frequent inactivation of the retinoblastoma anti-oncogene is restricted to a subset of human tumor cells.
1990 • 543 citations
Clonal Origin of Bladder Cancer
1992 • 538 citations
ROLE OF N-ACETYLTRANSFERASE PHENOTYPES IN BLADDER CARCINOGENESIS: A PHARMACOGENETIC EPIDEMIOLOGICAL APPROACH TO BLADDER CANCER
1982 • 501 citations
p53: At the Crossroads of Molecular Carcinogenesis and Risk Sssessment
1993 • 477 citations
p53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade, and stage in bladder cancer.
1993 • 464 citations
Familial Wiedemann-Beckwith syndrome and a second Wilms tumor locus both map to 11p15.5.
1989 • 448 citations
Structural Rearrangement of the Retinoblastoma Gene in Human Breast Carcinoma
1988 • 423 citations
Molecular Detection of Primary Bladder Cancer by Microsatellite Analysis
1996 • 396 citations
Altered Expression of the Retinoblastoma Gene Product: Prognostic Indicator in Bladder Cancer
1992 • 348 citations
Allelic losses of chromosomes 9, 11, and 17 in human bladder cancer.
1990 • 327 citations
Homozygous deletions within human chromosome band 9p21 in melanoma.
1992 • 319 citations
p53 and DNA polymerase α compete for binding to SV40 T antigen
1987 • 291 citations
Allelotype of human bladder cancer.
1994 • 265 citations
Frequent association of p53 gene mutation in Invasive bladder cancer
1992 • 265 citations
Over‐expression of p53 nuclear oncoprotein in transitional‐cell bladder cancer and its prognostic value
1993 • 264 citations
Altered Expression of Retinoblastoma Protein and Known Prognostic Variables in Locally Advanced Bladder Cancer
1992 • 254 citations
Allelic loss of chromosome 17p distinguishes high grade from low grade transitional cell carcinomas of the bladder.
1990 • 252 citations
Maintenance of p53 alterations throughout breast cancer progression.
1991 • 244 citations
Genetic alterations in bladder cancer
1993 • 243 citations
Numerical chromosome 1, 7, 9, and 11 aberrations in bladder cancer detected by in situ hybridization.
1991 • 233 citations
Molecular genetic alterations in superficial and locally advanced human bladder cancer.
1991 • 233 citations
Metachronous multifocal development of urothelial cancers by intraluminal seeding
1993 • 223 citations
Deletions of Interferon Genes in Acute Lymphoblastic Leukemia
1990 • 221 citations
Diagnosis and Management of Genitourinary Cancer
1988 • 208 citations
Molecular analysis of deletions of the short arm of chromosome 9 in human gliomas.
1992 • 187 citations
Microsatellite instability in bladder cancer.
1993 • 187 citations
Deletion of the p16 and p15 Genes in Human Bladder Tumors
1995 • 185 citations
Inactivation of the retinoblastoma gene in human bladder and renal cell carcinomas.
1991 • 184 citations
Expression of mutant p53, c-erbB-2 and the epidermal growth factor receptor in transitional cell carcinoma of the human urinary bladder
1991 • 181 citations
p16 (CDKN2) is a major deletion target at 9p21 in bladder cancer
1995 • 178 citations
Loss of heterozygosity at the RB locus is frequent and correlates with muscle invasion in bladder carcinoma.
1991 • 177 citations
ras Oncogene p21 expression is increased in premalignant lesions and high grade bladder carcinoma.
1985 • 173 citations
Nonrandom chromosomal changes in transitional cell carcinoma of the bladder.
1984 • 172 citations
Construction of a GT polymorphism map of human 9q
1992 • 171 citations
Review of Chromosome Studies in Urological Tumors. II. Cytogenetics and Molecular Genetics of Bladder Cancer
1994 • 171 citations
Role of chromosome 9 in human bladder cancer.
1993 • 166 citations
Deletion mapping of chromosome 8 in cancers of the urinary bladder using restriction fragment length polymorphisms and microsatellite polymorphisms.
1993 • 165 citations
Homozygous deletions of 9p21 in primary human bladder tumors detected by comparative multiplex polymerase chain reaction.
1994 • 164 citations
Loss of RB protein expression in primary bladder cancer correlates with loss of heterozygosity at the RB locus and tumor progression
1993 • 159 citations
Progressing toward a molecular description of colorectal cancer development
1992 • 148 citations
Chromosome 9 allelic losses and microsatellite alterations in human bladder tumors.
1994 • 147 citations
Evidence for two bladder cancer suppressor loci on human chromosome 9.
1993 • 143 citations
p53 immunohistochemistry as an independent prognostic factor for superficial transitional cell carcinoma of the bladder
1995 • 142 citations
Increased p16 levels correlate with pRb alterations in human urothelial cells.
1995 • 120 citations
Partial allelotype of carcinoma in situ of the human bladder.
1995 • 116 citations
Influence of cigarette smoking and schistosomiasis on p53 gene mutation in urothelial cancer.
1993 • 115 citations
Accumulated allelic losses in the development of invasive urothelial cancer
1993 • 115 citations
Detailed deletion mapping of chromosome 9q in bladder cancer: evidence for two tumour suppressor loci.
1995 • 108 citations
Novel suppressor loci on chromosome 14q in primary bladder cancer.
1995 • 108 citations
Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations.
1996 • 108 citations
Preliminary mapping of the deleted region of chromosome 9 in bladder cancer.
1993 • 104 citations
Definition of two regions of deletion on chromosome 9 in carcinoma of the bladder.
1994 • 104 citations
Bladder cancer in relation to cigarette smoking.
1988 • 104 citations
p53 immunohistochemistry in transitional cell carcinoma and dysplasia of the urinary bladder correlates with disease progression
1993 • 94 citations
Molecular Genetic Alterations of Chromosome 17 and p53 Nuclear Overexpression in Human Bladder Cancer
1993 • 94 citations
Retinoblastoma gene mutations in primary human bladder cancer
1995 • 88 citations
Human bladder carcinoma cell lines as indicators of oncogenic change relevant to urothelial neoplastic progression
1995 • 88 citations
Homozygous deletions within chromosomal bands 9p21-22 in bladder cancer.
1994 • 87 citations
Loss of heterozygosity on chromosome 18q is associated with muscle-invasive transitional cell carcinoma of the bladder
1994 • 75 citations
Tumor behavior in transitional cell carcinoma of the bladder in relation to chromosomal markers and histopathology.
1987 • 75 citations
High Frequency of Chromosome 9p Allelic Loss and CDKN2 Tumor Suppressor Gene Alterations in Squamous Cell Carcinoma of the Bladder
1995 • 74 citations
Pathways of development and progression in bladder cancer: new correlations between clinical observations and molecular mechanisms.
1993 • 72 citations
Mosaicism in Human Epithelium: Macroscopic Monoclonal Patches Cover the Urothelium
1995 • 71 citations
Characterization of chromosome 9 deletions in transitional cell carcinoma by microsatellite assay
1993 • 65 citations
Mutational spectrum in the p53 gene in bladder tumors from the endemic area of black foot disease in Taiwan
1994 • 64 citations
Homozygous deletion mapping at 9p21 in bladder carcinoma defines a critical region within 2cM of IFNA.
1994 • 61 citations
Expression of c-erbB-2 protein product in bladder cancer
1990 • 53 citations
Detection of the c‐myc Gene Product in Urinary Bladder Cancer
1990 • 52 citations
Nonrandom chromosome losses in stepwise neoplastic transformation in vitro of human uroepithelial cells.
1991 • 52 citations
Elevated expression of pp60c-src in low grade human bladder carcinoma.
1992 • 52 citations
p53 and Rb Immunostaining in Locally Advanced Bladder Cancer: Relation to Prognostic Variables and Predictive Value for the Local Response to Radical Radiotherapy
1995 • 50 citations
Prevalence of RAS oncogene mutation in head and neck carcinomas.
1992 • 42 citations
Chromosome changes in early bladder neoplasms
1992 • 33 citations
Loss of cyclin-dependent kinase inhibitor genes and chromosome 9 karyotypic abnormalities in human bladder cancer cell lines
1995 • 29 citations
Infrequent Somatic Mutation of the MTS1 Gene in Primary Bladder Carcinomas
1995 • 20 citations
Techniques in Cancer Cytogenetics: An Overview and Update
1992 • 10 citations
Radioactive Bullets Raise Cancer Fears
1993 • 5 citations
Basic research in urological oncology
1996 • 5 citations
The Molecular Progression of Bladder Cancer
2015 • 1 citations
Cited By (0)
No citing papers found in database